Company Performance: Samsung Biologics' financial health, revenue growth, profitability, and market share influence investor confidence and stock price.

Industry Trends: Overall performance and growth prospects of the biopharmaceutical industry, including regulatory changes, technological advancements, and competition, affect investor sentiment.

Market Conditions: Broad economic indicators like interest rates, inflation, and global economic growth can impact investor risk appetite and overall stock market performance, influencing the price of 014130.KO.

Regulatory Environment: Changes in regulations related to drug development, approval processes, and pricing policies can significantly affect Samsung Biologics' operations and profitability, thereby impacting its stock price.

Competition: The competitive landscape, including the emergence of new players, technological innovations, and pricing strategies of competitors, can affect Samsung Biologics' market position and stock value.

Investor Sentiment: Overall investor mood and expectations regarding Samsung Biologics' future prospects, which can be influenced by news, analyst ratings, and market rumors, affect buying and selling pressure.

Global Events: Geopolitical events, global health crises, and trade relations can create uncertainty in the market and impact investor sentiment towards the biopharmaceutical industry and Samsung Biologics.

Currency Fluctuations: As a global company, Samsung Biologics' financial performance is affected by currency exchange rates, which can impact its revenue and profitability, thereby affecting its stock price.

Specific News: Company-specific announcements, such as earnings reports, new product launches, clinical trial results, and strategic partnerships, directly influence investor perception and stock price.

Technological Advancements: Breakthroughs in biotechnology and biomanufacturing can significantly impact Samsung Biologics' competitive advantage and future growth potential, influencing its stock price.